Pluma, Jayson .
HRN: 21-60-92 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/03/2024
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
07/03/2024
07/03/2024
IVTT
4.5 G
Stat Dose
Infected Wound, Sepsis
Waiting Final Action
Indication: EmpiricEmpirical Escalation Type of Infection: BloodstreamSkin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes